chloroethylaminouracil
structure
Also Known As:
4-methyl-5-(bis(beta-chloroethyl)amino)uracil; 6-methyluracil mustard; dopan
Networked: 16
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Inflammation (Inflammations)
05/06/2019
- " The work suggests inflammation and redox imbalance as simultaneous early mechanisms undergoing DOPAn sufferance, to be targeted for a causative treatment aimed to stop/delay PD." 05/06/2019
- " Alteration in the redox state and inflammation started at 3 h, preceding the reduction in DOPAn number (pre-diagnosis phase). " 07/14/2023
- " Dopaminergic neurons (DOPAn) are susceptible to stressors, and inflammation is a recognized risk for neuronal malfunctioning and cell death in major neurodegenerative diseases. " 11/17/2022
- " On the contrary, inflammation, specifically tumor necrosis factor alpha (TNF-α), was found to be the key to UCB protection against DOPAn sufferance. " 07/14/2023
- " This review summarizes the evidence linking DOPAn, inflammation (when possible, specifically TNFα), and bilirubin as an anti-inflammatory in order to understand what is known, the gaps that need filling, and the hypotheses of anti-inflammatory strategies to preserve dopamine homeostasis with bilirubin included."
|
2. | Poisoning
|
3. | Neoplasms (Cancer)
|
4. | Neurodegenerative Diseases (Neurodegenerative Disease)
|
5. | B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
|
|
Related Drugs and Biologics
Related Therapies and Procedures